GleamWall
中文EN

Foresite Capital Management V, LLC

WEST HOLLYWOOD CA · SEC CIK 0001792206

2026Q22026Q1 9 earlier quarters 🔒
$362.20M2026Q2 reported value
9Positions
100.0%Top 10 weight · largest 45.8%
0 / 1New / sold out
Reported value over time$362.20M2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

ALMS 45.8%
CGON 21.2%
IRON 7.6%
HIMS 7.1%
PHVS 6.3%
EIKN 4.8%
ODTX 3.7%
LYEL 1.8%
NRIX 1.8%

2026Q2 top buys estimated at quarter-end value

PHVS Added+$16.25M
CGON Added+$5.33M

2026Q2 top sells estimated at quarter-end value

MAZE Sold out-$773,264
LYEL Reduced-$9,723

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
ALMS ALUMIS INC. $165.94M45.81%5,896,995 00.0% — Unchanged
CGON CG Oncology, Inc. $76.67M21.17%1,079,050 75,0007.5% $5.33M Added
IRON Disc Medicine, Inc. $27.36M7.55%374,069 00.0% — Unchanged
HIMS Hims & Hers Health, Inc. $25.59M7.07%738,151 00.0% — Unchanged
PHVS Pharvaris N.V. $22.97M6.34%664,142 470,017242.1% $16.25M Added
EIKN Eikon Therapeutics, Inc. $17.21M4.75%1,318,983 00.0% — Unchanged
ODTX Odyssey Therapeutics, Inc. $13.34M3.68%713,105 713,105— — First reported
LYEL Lyell Immunopharma, Inc. $6.69M1.85%476,386 -692-0.1% -$9,723 Reduced
NRIX Nurix Therapeutics, Inc. $6.43M1.77%265,000 00.0% — Unchanged
MAZE Maze Therapeutics, Inc. $00.00%0 -25,905-100.0% -$773,264 Sold out